FisherBroyles Partner, Brian E. Dickerson, has recently been quoted in Law 360 article, “Generic Price Fixing Suits Just Tip of the Iceberg.”

This article focuses on the recent acts of the U.S. Department of Justice and state attorneys general who have sued generic drug companies and executives over allegations of price-fixing and market-sharing — and more suits are expected by experts in 2017.

Dickerson weighs in and is quoted as follows:

Government investigations into the industry could also balloon to cover entities at different levels of the generic-drug food chain. Some states have been sending document requests to wholesalers and pharmacies, seeking information on drug pricing and promotion, according to Brian E. Dickerson of FisherBroyles LLP.

“This is going to end up being an industrywide investigation,” Dickerson said. “I think it will include more manufacturers, and it’s also going to include wholesalers as well.”


While the investigation into the generic drug industry, which has been ongoing since at

least the end of 2014, was not predicated by the furor, it certainly won’t make it easier for manufacturers to respond to lawsuits, Dickerson said.

“They’re going to have to be very strategic in how they defend themselves,” he said. Generic drug makers will also have to watch their behavior going forward so as not to draw even more scrutiny, Dickerson said.


You can read the full article, by clicking here: